Mostrar el registro sencillo del ítem

dc.contributor.authorRamos Casals, Manuel
dc.contributor.authorBrito Zerón, Pilar
dc.contributor.authorPerez De LiS, Marta
dc.contributor.authorJimenez, Iratxe
dc.contributor.authorBlanco, Maria Jose
dc.contributor.authorBove, Albert
dc.contributor.authorSoto Cardenas, María José 
dc.contributor.authorAkasbi, Miriam
dc.contributor.authorDiaz, Candido
dc.contributor.authorSentís, Juan
dc.contributor.authorSiso, Antoni
dc.contributor.otherCirugíaes_ES
dc.contributor.otherMedicinaes_ES
dc.date.accessioned2026-04-08T06:55:53Z
dc.date.available2026-04-08T06:55:53Z
dc.date.issued2009-07
dc.identifier.issn1080-0549
dc.identifier.urihttp://hdl.handle.net/10498/39214
dc.description.abstractThe current 2002 classification criteria do not cover the broad clinical and immunological heterogeneity of primary Sjögren syndrome (SS), since five of the six criteria focus exclusively on glandular involvement and the remaining criterion is the mandatory presence of anti-Ro/La antibodies. The aim of this study was to analyze the clinical features of patients with a well-established diagnosis of primary SS who do not fulfill the 2002 classification criteria. Five hundred seven patients diagnosed with primary SS (1993 criteria) were consecutively included and followed up. Two hundred twenty-one (44%) patients did not fulfill the 2002 criteria. These patients were older at diagnosis (p < 0.001) and had a lower frequency of parotid enlargement (p = 0.002), fever (p = 0.041), arthritis (p = 0.041), vasculitis (p = 0.050), peripheral neuropathy (p = 0.002), cranial nerve involvement (p = 0.015), raised erythrocyte sedimentation rate ( ESR) levels (p < 0.001), anemia (p < 0.001), leukopenia (p = 0.037), hypergammaglobulinemia (p < 0.001), positive rheumatoid factor ( RF; p = 0.002), and cryoglobulinemia (p = 0.049) in comparison with those fulfilling 2002 criteria. However, there were no significant differences in the prevalence of sicca features, diagnostic tests, overall systemic involvement, antinuclear antibodies , complement levels, development of B-cell lymphoma, or survival. Patients with anti-Ro antibodies had the highest frequencies of systemic features, hematological abnormalities, and altered immunological markers. In conclusion, patients fulfilling the 2002 criteria, who have either a specific histological diagnosis (lymphocytic infiltration) or highly specific autoantibodies (Ro/La), might well be considered to have Sjögren "disease." In contrast, etiopathogenic mechanisms other than lymphocytic-mediated epithelial damage could be involved in patients with negative Ro and negative biopsy, in whom the term Sjögren "syndrome" seems more adequate.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherHumana Presses_ES
dc.rightsAttribution 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceClinical Reviews in Allergy and Immunology (2010) Vol. 38, nº 2-3, pp. 178–185es_ES
dc.subjectSjogren's syndromees_ES
dc.subjectAnti-Ro/SS-A antibodieses_ES
dc.subjectSalivary gland biopsyes_ES
dc.titleSjögren syndrome or sjögren disease? The histological and immunological bias caused by the 2002 criteriaes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsclosed accesses_ES
dc.identifier.doi10.1007/s12016-009-8152-z
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution 4.0 Internacional
Esta obra está bajo una Licencia Creative Commons Attribution 4.0 Internacional